advertisement
11.3.3 Apraclonidine, brimonidine (8)
Showing records 1 to 8
Display all abstracts in classification 11.3.3 Apraclonidine, brimonidine
Search within classification 11.3.3 Apraclonidine, brimonidine18381 The one-month effects of topical betaxolol, dorzolamide and apraclonidine on ocular blood flow velocities in patients with newly diagnosed primary open-angle glaucoma
Avunduk AM; Sari A; Akyol N; Öztürk O; Kapicioglu Z; Erdöl H; Imamoglu HI
Ophthalmologica 2001; 215: 361-365
18380 Brimonidine (Alphagan™): a clinical profile four years after launch
David R
European Journal of Ophthalmology 2001; 11: Suppl 2 S72-S77
18379 Comparative evaluation of the tolerability of proxofelin and clofelin and their effects on the eye in patients with glaucoma
Ermakova VN; Malinina SL; Abdulkadyrova MZ
Vestnik Oftalmologii 2001; 117: 6-8
18378 Influence of topical brimonidine on visual field in glaucoma
Ruiz Lapuente C; Ruiz Lapuente A; Link B
European Journal of Ophthalmology 2001; 11 Suppl: 2 S67-S71
18377 Acute and chronic effects of brimonidine 0.2% on intraocular pressure and pulsatile ocular blood flow in patients with primary open-angle glaucoma: an open-label, uncontrolled, prospective study
Vetrugno M; Maino A; Cantatore F; Ruggeri G; Cardia L
Clinical Therapeutics 2001; 23: 1519-1528
18376 Brimonidine's neuroprotective effects against transient ischaemia-induced retinal ganglion cell death
Vidal-Sanz M; Lafuente MP; Mayor-Torroglosa S; Aguilera ME; Miralles de Imperial J; Villegas-Perez MP
European Journal of Ophthalmology 2001; 11: Suppl 2 S36-S40
18375 Alpha-2 adrenergic receptor agonists are neuroprotective in experimental models of glaucoma
Wheeler LA; Woldemussie E
European Journal of Ophthalmology 2001; 11: Suppl 2 S30-S35
18374 Neuroprotection of retinal ganglion cells by brimonidine in rats with laser-induced chronic ocular hypertension
Woldemussie E; Ruiz G; Wijono M; Wheeler LA
Investigative Ophthalmology and Visual Science 2001; 42: 2849-2855